Salud

Vacuna de AstraZeneca contra covid-19 no aumenta riesgo de coágulos, confirma Agencia Europea del Medicamento

Ante casos de trombosis registrados en personas que se vacunaron, sí se recomienda anotarlos como eventos ‘muy raros’ dentro del prospecto. Se reanuda inoculación en países europeos

(FILES) This file photo taken on February 12, 2021 shows a box of AstraZeneca's Covid-19 vaccine at the university hospital, at the start of the inoculation with the AstraZeneca vaccine at the hospital, in Halle/Saale, eastern Germany. - Lithuania on March 16, 2021 followed more than a dozen other countries in suspending AstraZeneca vaccinations pending checks by the European Medicines Agency (EMA). Health Minister Arunas Dulkys said the vaccine will not be used as a precaution "until the European Medicines Agency provides its final conclusions over its safety". (Photo by JENS SCHLUETER / AFP)
(FILES) This file photo taken on February 12, 2021 shows a box of AstraZeneca's Covid-19 vaccine at the university hospital, at the start of the inoculation with the AstraZeneca vaccine at the hospital, in Halle/Saale, eastern Germany. - Lithuania on March 16, 2021 followed more than a dozen other countries in suspending AstraZeneca vaccinations pending checks by the European Medicines Agency (EMA). Health Minister Arunas Dulkys said the vaccine will not be used as a precaution "until the European Medicines Agency provides its final conclusions over its safety". (Photo by JENS SCHLUETER / AFP) JENS SCHLUETER
‌
‌

‌

‌
‌

‌

‌